In MDA-MB-231 breast and SKOV-3 ovarian cancer cells, HA molecules of 500 kDa and 1000 kDa indirectly activate Rho pathways through CD44, promoting cell growth and migration. This evidence concerns the gene CD44 and ovarian carcinoma.